Clinical Trial Update: ChemoFx® PRO - A Post-Market Data Collection Study

View source ↗

Summary

The post-market data collection study ChemoFx PRO by Precision Therapeutics has been terminated, with data collection across ovarian and related gynecologic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Uterine Neoplasms
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• ChemoFx PRO

Snippet

Sponsor: Precision Therapeutics | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Status: TERMINATED